{"Ticker": "INCY", "Company": "Incyte", "Sector": "Health Care", "Updated": "2021-11-19", "Rating": [{"Date": "2021-11-19", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$75"}, {"Date": "2021-07-20", "Rating": "Upgrade", "Organization": "The Benchmark Company", "Rating_Change": "Hold to Buy", "Target_Change": "$89"}, {"Date": "2021-02-10", "Rating": "Downgrade", "Organization": "SVB Leerink", "Rating_Change": "Mkt Perform to Underperform", "Target_Change": "$70"}, {"Date": "2021-01-07", "Rating": "Initiated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$120"}, {"Date": "2021-01-04", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2020-06-16", "Rating": "Initiated", "Organization": "The Benchmark Company", "Rating_Change": "Hold", "Target_Change": ""}, {"Date": "2020-05-06", "Rating": "Downgrade", "Organization": "JP Morgan", "Rating_Change": "Overweight to Neutral", "Target_Change": "$89 to $99"}, {"Date": "2020-04-29", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$94"}, {"Date": "2020-04-01", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight to Overweight", "Target_Change": "$83 to $90"}, {"Date": "2020-03-24", "Rating": "Resumed", "Organization": "William Blair", "Rating_Change": "Outperform", "Target_Change": ""}, {"Date": "2020-03-13", "Rating": "Upgrade", "Organization": "BofA/Merrill", "Rating_Change": "Neutral to Buy", "Target_Change": "$83"}, {"Date": "2020-02-04", "Rating": "Resumed", "Organization": "BofA/Merrill", "Rating_Change": "Neutral", "Target_Change": "$82"}, {"Date": "2020-01-03", "Rating": "Reiterated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": "$85 to $74"}, {"Date": "2020-01-03", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": "$98 to $79"}, {"Date": "2020-01-02", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2019-10-03", "Rating": "Initiated", "Organization": "Mizuho", "Rating_Change": "Buy", "Target_Change": "$95"}, {"Date": "2019-09-12", "Rating": "Initiated", "Organization": "BMO Capital Markets", "Rating_Change": "Market Perform", "Target_Change": ""}, {"Date": "2019-09-05", "Rating": "Upgrade", "Organization": "Oppenheimer", "Rating_Change": "Perform to Outperform", "Target_Change": "$100"}, {"Date": "2019-09-05", "Rating": "Upgrade", "Organization": "JMP Securities", "Rating_Change": "Mkt Perform to Mkt Outperform", "Target_Change": "$107"}, {"Date": "2019-09-05", "Rating": "Resumed", "Organization": "Morgan Stanley", "Rating_Change": "Equal-Weight", "Target_Change": "$82 to $87"}]}